baber/WOPTO huggingface dataset:
Patent AU-2815892-A (AU)
Title: A piston compressor for the oilfree compression of gases
IPC: F16J9/28
Filed: 1992-11-05
Abstract: The piston (6) guided in a cylinder (1) has at least one split "captive" piston ring (10) accommodated in an annular groove on the piston. With the circumferential surface (12) facing away from the inner surface (11) of the cylinder, the piston ring delimits a space (23) in the annular groove subjected to the pressure of the gas in the compression space. Starting from this circumferential surface (12), the piston ring has two radial, mutually parallel boundary surfaces (13, 14), of which the surface (14) facing the compression space extends over part of the radial width of the ring. The piston ring (10) is guided in sliding fashion on corresponding surfaces of the annular groove by its two parallel boundary surfaces (13, 14). The remaining surface (16) of the piston ring, the surface facing the compression space, is, starting from the circumferential surface (15) facing the inner surface (11) of the cylinder, designed as a wedge surface which extends at an angle of 5 to 15 DEG  to a line parallel to the boundary surface (14) facing the compression space, extending as far as this boundary surface. The annular-groove surface adjacent to the wedge surface (16) also extends at the same angle parallel to the wedge surface (16). <IMAGE>
Patent AU-2884699-A (AU)
Title: Method and system for creating three-dimensional images using tomosynthetic computed tomography
Inventor: WEBBER RICHARD L
IPC: A61B6/02
Filed: 1999-02-26
Abstract: A system for constructing image slices through a selected object, the system comprising an identifiable fiducial reference in a fixed position relative to the selected object, wherein the fiducial reference comprises at least two identifiable reference markers. A source of radiation is provided for irradiating the selected object and the fiducial reference to form a projected image of the selected object and the fiducial reference which is recorded by a recording medium.
Patent AU-2979199-A (AU)
Title: Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
Inventor: RESNICK MARK G
IPC: A61P17/02
Filed: 1999-03-03
Abstract: The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the administration of compositions containing selegiline and/or desmethylselegiline.
Patent AU-2981592-A (AU)
Title: Novel fumaric acid salts
IPC: A61K31/495
Filed: 1992-12-02
Abstract: 1,5-Fumaric acid salts of N,N'-di-lower alkyl-substituted 9,9-alkylene-3,7-diazabicyclo[3.3.1]nonanes are described. The salts are obtained in stoichiometrically pure form and are virtually non-hygroscopic.
Patent AU-3069792-A (AU)
Title: Corneal surgery device and method
IPC: B23K26/00
Filed: 1992-11-05
Abstract: A laser apparatus includes an eye tracking system for biasing the alignment of the position of a laser beam with respect to the cornea of an eye which comprises indicator means providing visible indications of movement of the eye, sensor means for detecting the visible indications, and laser beam positioning means coupled to the sensor means for biasing the alignment of the laser beam. The apparatus preferably further includes a guide beam generation system for generating a visible guide beam coaxial with laser pulses, and a wavelength converter for converting the fundamental wavelengths of original incident laser pulses in to corresponding second harmonic wavelengths. Methods of tracking the movement of an eye, generating a guide beam, and converting the wavelength of a laser, are also disclosed. <IMAGE>
Patent AU-3115500-A (AU)
Title: In mold addition polymerization of norbornene-type monomers using group 10 metal complexes
Inventor: BELL ANDREW
IPC: C08F4/80
Filed: 1999-12-08
Abstract: A catalyst system and a process for the bulk addition polymerization or of polycyclic olefins, such as norbornene, methylnorbornene, ethylnorbornene, butylnorbornene or hexylnorbornene, 1,2,3,4,4a,5,8,8a-octahydro-1,4:5,8-dimethanonapthalene, 5,5'-(1,2-ethanediyl)bisbicyclo[2.2.1]hept-2-ene, and 1,4,4a,4b,5,8,8a,8b-octahydro-1,4:5,8-dimethanobiphenylene are disclosed. The catalyst includes an organonickel or organopalladium transition metal procatalyst and an activator compound. Polymerization can be carried out in a reaction injection molding process to yield thermoplastic and thermoset molded polymeric articles possessing high glass transition temperatures.
Patent AU-3220493-A (AU)
Title: Unique label generation apparatus for entity
IPC: B41J5/30
Filed: 1992-11-18
Abstract: The label generation apparatus of this invention enables the user to define a label of various sizes, shapes and characteristics, wherein each label in a series of labels includes unique indicia that individually identify each label according to any predefined sequence. These labels also contain template fields that vary according to the indicia printed thereon or any other predefined ordering. The label generation apparatus includes a template generation capability that enables the user to define a label format having one or more writable indicia fields. These one or more writable indicia fields can be used to provide each label with individual identifying indicia according to any predetermined sequence. The label generation apparatus also includes an indicia generation capability that produces the individual identification according to various characteristics that are specified by the user of this apparatus.
Patent AU-3307797-A (AU)
Title: A method for increasing hemoprotein production in filamentous fungi
Inventor: ELROD SUSAN L
IPC: C12N9/08
Filed: 1997-06-09
Abstract: The present invention relates to methods of producing hemoproteins comprising (a) introducing into a filamentous fungal cell, which is capable of producing the hemoprotein, (i) one or more first control sequences capable of directing the expression of a heme biosynthetic enzyme encoded by a first nucleic acid sequence endogenous to the filamentous fungal cell, wherein the one or more of the first control sequences are operably linked to the first nucleic acid sequence; and/or (ii) one or more copies of one or more second nucleic acid sequences encoding a heme biosynthetic enzyme; (b) cultivating the filamentous fungal cell in a nutrient medium suitable for production of the hemoprotein and the heme biosynthetic enzymes; and (c) recovering the hemoprotein from the nutrient medium of the filamentous fungal cell.
Patent AU-3380899-A (AU)
Title: Methods for reducing cholesterol using (bacillus coagulans) spores, systems and compositions
Inventor: FARMER SEAN
IPC: A61K35/74
Filed: 1999-04-01
Abstract: The invention describes therapeutic compositions including a lactic acid-producing bacteria, such as isolated Bacillus coagulans, in combination with a bifidogenic oligosaccharides or other cholesterol-reducing agents for use in reducing LDL cholesterol and serum triglycerides. Also described are therapeutic methods using the compositions and systems containing the therapeutic compositions.
Patent AU-3689500-A (AU)
Title: Implantable drug delivery system
Inventor: ELFVER STEN-OLOF
IPC: A61M5/142
Filed: 2000-03-10
Abstract: Implantable drug delivery system comprising a reservoir module provided with a drug reservoir and a drug expelling means arranged to expel a drug liquid from said drug reservoir to a dispenser module that comprises a predetermined number of drug delivery openings for delivering a drug, received from said drug reservoir, to tissue.
Patent AU-3821399-A (AU)
Title: Aerosol formulations of salmeterol xinafoate
Inventor: COOPER SIMON MURRAY
IPC: A61K31/135
Filed: 1999-04-23
Abstract: The present invention relates to formulations comprising particulate products which may be prepared by methods and apparatus using supercritical fluids. More particularly, the invention relates to formulations comprising certain crystalline forms of 4-hydroxy-alpha1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (salmeterol) 1-hydroxy-2-naphthalenecarboxylate (xinafoate). Accordingly, the present invention provides an aerosol pharmaceutical formulation comprising salmeterol xinafoate with a controlled particle size, shape and morphology, and a fluorocarbon, hydrogen-containing fluorocarbon or hydrogen-containing chlorofluorocarbon propellant.
Patent AU-3900589-A (AU)
Title: Antigenic constructs of major histocompatibility complex class 1 antigens with specific carrier molecules, the preparation and use thereof
Inventor: SEEMANN GERHARD
IPC: C07K19/00
Filed: 1989-07-27
Abstract: Antigen constructs which result from linkage of major histocompatibility complex (MHC) Class I antigens to specific carrier molecules are described. The linkage takes place at the N or C terminus by covalent bonding or, in the case of non-covalent bonding, e.g. via avidin-biotin bridging. The specific carrier molecules bind selectively to target cells and are preferably monoclonal antibodies. Genetic engineering processes for the production of such constructs are indicated. Antigen constructs according to the invention are used for damaging or eliminating target cells. <IMAGE>
Patent AU-4219499-A (AU)
Title: Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
Inventor: HOLLINGSWORTH RAWLE I
IPC: C07C231/02
Filed: 1999-05-28
Abstract: A process for the preparation of protected dihydroxypropyl trialkylammonium salts, particularly in chiral form is described. In particular, a process for the preparation of (2,2-dimethyl-1,3-dioxolan-4-ylmethyl)trialkylammonium salts, particularly in chiral form is described. Furthermore, a process is described wherein the (2,2-dimethyl-1,3-dioxolan-4ylmethyl)trialkylammonium salts is a 2,2-dimethyl-1,3-dioxolan-4-ylmethyl trimethylammonium salt, preferably in chiral form. The protected dihydroxypropyl trialkylammonium salts lead to L-carnitine (9) when in chiral form (5).
Patent AU-4225893-A (AU)
Title: Method for reducing tackniness of soft acrylic polymers
Inventor: LEBOEUF ALBERT R
IPC: C08J3/12
Filed: 1993-04-30
Abstract: The tackiness associated with certain soft acrylic polymers can be reduced by plasma treatment of the polymer surface. This is particularly useful with regard to intraocular lenses (IOLs), especially foldable IOLs, which are made from such soft acrylic polymers.
Patent AU-4294197-A (AU)
Title: Method and device for the one-handed input of data
Inventor: REIN WOLF HEIDER
IPC: G06F3/023
Filed: 1997-08-21
Abstract: The invention concerns a device for the one-handed input of coordinates of multi-axis coordinate systems and alphanumeric characters and control commands, the device being operable with one hand. The forearm does not participate in the movements and rests on a support. The device comprises a plurality of elongated keys having sensor surfaces which, when depressed, detect and evaluate the position of a fingertip as a coordinate. The device comprises a housing which detects and evaluates the ulnar pivot movement of the hand as a horizontal coordinate and the pronation of the hand and a translation in the direction of the arm as control signals. The device combines the input functions of a mouse and a keyboard.
Patent AU-4335993-A (AU)
Title: Sheet material, method of producing same and rolls for use in the method
Inventor: DEELEY GEOFFREY THOMAS
IPC: B21D13/04
Filed: 1993-05-28
Abstract: PCT No. PCT/GB93/01117 Sec. 371 Date Apr. 15, 1995 Sec. 102(e) Date May 15, 1995 PCT Filed Feb. 8, 1993 PCT Pub. No. WO94/12294 PCT Pub. Date Jun. 9, 1994A stud for use in partitioning is formed by passing plain sheet material between a pair of rolls (18, 19), each having projections, to form projections at both of the opposite surfaces of the material and then roll-forming the material to a channel, the positions of the projections and recesses at each surface of the material being such that lines drawn on a surface of the material between adjacent rows of projections and depressions are not rectilinear.
Patent AU-4377385-A (AU)
Title: Tap with reverse flow check
Inventor: SCHLOTMAN WALTER F
IPC: F16K15/18
Filed: 1985-06-18
Abstract: A fluid valve includes a sleeve (10) having an inlet (16) and an outlet (18). There ist a stem (34) movable within the sleeve (10) and having an inlet (68) and an outlet (72), with the stem inlet (68) being in communication with the sleeve inlet (16) and the stem outlet (72) being movable into communication with the sleeve outlet (18) to define a path of flow through the valve from the communicating inlets through the stem outlet (72) and the sleeve outlet (18). There is a check valve (62) movable within the stem (34). Water flowing in the direction of the path of flow maintaining the check valve (62) in a position unrestrictive to the path of flow. When water flows in a direction opposite to the path of flow, the check valve (62) will close the path of flow.
Patent AU-4577997-A (AU)
Title: Method and device for registering the outer characteristics of a vehicle in a road toll unit
Inventor: BOSTROM GORAN
IPC: G07B15/06
Filed: 1997-10-03
Abstract: A method and a device for image registration of the external characteristics and the number plate of a vehicle in a road toll unit for checking the payment status relating to a toll fee, which is intended to be collected by means of remote communication. During the checking and payment operation, the vehicle is followed by successive video recordings. In these recordings, a marker is connected to the vehicle. The same marker is connected to the image of the number plate and to an image of the physical shape of the vehicle. In the event of incorrect payment, a search may be performed based upon both the image of the number plate and the associated image of the physical shape of the vehicle, which are connected together by means of the successive following of the position of the vehicle. The class of the vehicle may thus be determined, in accordance with a classification scheme based on the physical properties of the vehicle, from the image of the external characteristics of the vehicle for determining the toll fee.
Patent AU-4617996-A (AU)
Title: Use of hyaluronic acid for the treatment of cystitis
Inventor: MORALES ALVARO
IPC: A61K31/715
Filed: 1996-02-14
Abstract: A method of treating interstitial cystitis comprising contacting the transitional epithelium lining the urinary bladder and associated structures in a mammal having interstitial cystitis with a solution containing hyaluronic acid having a average molecular weight of not less than 2x105 Daltons in a concentration effective to treat the interstitial cystitis.
Patent AU-4771401-A (AU)
Title: Oxygen reduced niobium oxides
Inventor: KIMMEL JONATHON L
IPC: C04B35/638
Filed: 2001-03-22
Abstract: Methods to at least partially reduce a niobium oxide are described wherein the process includes heat treating the niobium oxide in the presence of a getter material and in an atmosphere which permits the transfer of oxygen atoms from the niobium oxide to the getter material, and for a sufficient time and at a sufficient temperature to form an oxygen reduced niobium oxide. Niobium oxides and/or suboxides are also described as well as capacitors containing anodes made from the niobium oxides and suboxides. Anodes formed from niobium oxide powders using binders and/or lubricants are described as well as methods to form the anodes.
Patent AU-5035290-A (AU)
Title: Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
Inventor: STANLEY THEODORE H
IPC: A61K38/095
Filed: 1989-09-05
Abstract: The present invention is directed to methods and compositions for noninvasively administering lipophilic drugs in a dose-to-effect manner to produce antimigraine, oxytoxic, antiemetic, hypoglycemic, anti-Parkinsonian, antidiuretic, antifungal, antisecretory, or bronchodilator activity. A patient is put at ease when given the lollipop, and the lipophilic drug rapidly enters the patient's bloodstream as the lollipop is sucked. When treating the patient, the physician can observe the patient's condition and terminate the use of the lollipop when it has had a desired effect on the patient. The drug-containing lollipop can be self-administered by the patient in response to subjective symptoms and to the patient's susceptibility to the lipophilic drug.
Patent AU-5089298-A (AU)
Title: Hair shaving device with u-shaped razor blade strip
Inventor: ANDREWS EDWARD A
IPC: B26B21/22
Filed: 1997-10-28
Abstract: A manually operated, finger-manipulatable non-electric hair trimming device for shaving nostril hair, ear hair or the like, includes a head structure sized to fit within a small body cavity, such as a person's nostril or ear cavity, which includes a flexible razor blade strip. The head structure has a base portion and a curved guard portion, which preferably has first and second ends which are attached to the base portion. A finger grip portion is connected to the base portion to allow precise manual manipulation of the hair trimming device. The head structure further has a thin, elongated narrow razor blade strip with a razor sharp first edge portion, which may be a serrated edge with razor-sharp notches such as V-slots or may be a conventional straight edge. Alternatively, two razor-sharp edges, one serrated and one straight, may be provided. The razor blade strip preferably has an inverted U-shape, made by flexing it to extend substantially along the curved guard portion of the head structure, which may serve as the blade strip platform. The guard may have fingers which extend beyond the razor's edge with blade-exposing recesses therebetween.
Patent AU-5102399-A (AU)
Title: Arrays of protein-capture agents and methods of use thereof
Inventor: WAGNER PETER
IPC: G01N33/543
Filed: 1999-07-14
Abstract: Arrays of protein-capture agents useful for the simultaneous detection of a plurality of proteins which are the expression products, or fragments thereof, of a cell or population of cells in an organism are provided. A variety of antibody arrays, in particular, are described. Methods of both making and using the arrays of protein-capture agents are also disclosed. The invention arrays are particularly useful for various proteomics applications including assessing patterns of protein expression and modification in cells.
Patent AU-5232786-A (AU)
Title: Process for irreversible recording, recording support and use of the process or of the recording support
Inventor: WORNDLI GERHARD A
IPC: G09B3/04
Filed: 1985-12-19
Abstract: PCT No. PCT/CH85/00177 Sec. 371 Date Nov. 18, 1987 Sec. 102(e) Date Nov. 18, 1987 PCT Filed Dec. 19, 1985 PCT Pub. No. WO87/03990 PCT Pub. Date Jul. 2, 1987.In order, for example to produce solution noting/check-out sheets, such as are used in correspondence courses, so that a sheet of writing paper can be written on externally only up to the time when information concerning the correct solution to the problem is made known to the person writing on it, a sheet of writing paper comprises two sheets (1, 3) joined together on three edges (15) and an intermediate sheet (5). The intermediate sheet (5) ensures that when the paper is written on in a writing area (17) the information is transferred to one of the sheets (1, 3). An adhesive place (11) is provided between the sheets (1, 3) which does not adhere to the intermediate sheet (5) but indissolubly binds the two sheets (1, 3) when the intermediate sheet is removed. Located in an information area (19) is the correct solution, which cannot be seen while an intermediate sheet is inserted (15), so that the user can learn the correct solution only after the intermediate sheet (5) has been withdrawn, at a moment when the adhesive place (11) is already activated and therefore any correction and/or completion in the writing area (17) is rendered impossible.
Patent AU-5442400-A (AU)
Title: Indole-type derivatives as inhibitors of p38 kinase
Inventor: MAVUNKEL BABU J
IPC: A61P1/04
Filed: 2000-05-19
Abstract: The invention is directed to methods to inhibit p38- alpha  kinase using compounds of formula (1), and the pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof, wherein (a) represents a single or double bond; one Z<2> is CA or CR<8>A and the other is CR<1>, CR<1>2, NR<6> or N wherein each R<1>, R<6> and R<8> is independently hydrogen or noninterfering substituent; A is -Wi-COXjY wherein Y is COR<2> or an isostere thereof and R<2> is hydrogen or a noninterfering substituent, each of W and X is a spacer of 2-6 ANGSTROM , and each of i and j is independently 0 or 1; Z<3> is NR<7> or O; each R<3> is independently a noninterfering substituent; n is 0-3; each of L<1> and L<2> is a linker; each R<4> is independently a noninterfering substituent; m is 0-4; Z<1> is CR<5> or N wherein R<5> is hydrogen or a noninterfering substituent; each of l and k is an integer from 0-2 wherein the sum of l and k is 0-3; Ar is an aryl group substituted with 0-5 noninterfering substituents, wherein two noninterfering substituents can form a fused ring; and the distance between the atom of Ar linked to L<2> and the center of the  alpha  ring is 4.5-24 ANGSTROM .
Patent AU-5575186-A (AU)
Title: Substituted anthrapyrazolones
Inventor: JOHNSON JUDITH L
IPC: C07D231/54
Filed: 1986-04-08
Abstract: An improved process for making anthra[1,9-od]-pyrazol--6(2H)-ones of formulafrom 1,4-dichloro-5,8-disubstituted-9,10-anthracenediones of formulaand a hydrazine and a diamine is disclosed. The compounds produced have antibacterial, antifungal, antileukaemic, and antitumor activity.
Patent AU-5603200-A (AU)
Title: Methods for modulating fxr receptor activity
Inventor: FORMAN BARRY M
IPC: A61K31/553
Filed: 2000-06-09
Abstract: Methods for modulating the activity of the mammalian FXR receptor. The methods include methods of treating a hyper- or hypocholesterolemic mammal comprising contacting the mammal with synthetic compounds having FXR receptor activity.
Patent AU-5653694-A (AU)
Title: Effervescent pharmaceutical composition containing ibuprofenand method for preparing same
Inventor: BRU-MAGNIEZ NICOLE
IPC: A61K31/192
Filed: 1993-12-09
Abstract: The present invention relates to a novel pharmaceutical composition for the preparation of effervescent powders or tablets incorporating ibuprofen or one of its pharmaceutically acceptable salts as the active ingredient. This composition comprises: an effective amount of ibuprofen or one of its pharmaceutically acceptable salts; a pharmaceutically acceptable effervescent system comprising at least one alkaline carbonate and at least one organic acid, preferably in a sufficient amount to give a pH below about 8; and at least one pharmaceutically acceptable antioxidant in a sufficient amount to stabilize the ibuprofen. This composition has a remarkable stability both in powder form and in tablet form.
Patent AU-5763800-A (AU)
Title: Extractive distillation separation
Inventor: GUPTA VIJAI P
IPC: C07C27/02
Filed: 2000-06-23
Abstract: High purity tertiary butyl alcohol is obtained from mixtures comprised of tertiary butyl alcohol and tertiary butyl acetate by extractive distillation using a hydrocarbon extractive solvent such as decane.